S. Paukner

发表

B. Ranjbar, F. Najafi, A. Ziaee, 2008 .

Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance.

S. Paukner, R. Riedl, 2017, Cold Spring Harbor perspectives in medicine.

Bacterial Ghosts Are an Efficient Delivery System for DNA Vaccines1

W. Lubitz, T. Ebensen, C. Guzmán, 2004, The Journal of Immunology.

Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model

B. Hrvačić, S. Paukner, S. Gelone, 2021, PloS one.

Sealed Bacterial Ghosts—Novel Targeting Vehicles for Advanced Drug Delivery of Water-soluble Substances

W. Lubitz, S. Paukner, K. Jalava, 2003 .

A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism

A. Bashan, A. Yonath, H. Rozenberg, 2016, Scientific Reports.

Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae

S. Paukner, W. Wicha, D. Strickmann, 2019, The Journal of antimicrobial chemotherapy.

Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015–2016)

S. Paukner, S. Gelone, H. Sader, 2019, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States

S. Paukner, D. Farrell, G. Talbot, 2016, Antimicrobial Agents and Chemotherapy.

Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial.

S. Paukner, G. Moran, Anita F. Das, 2019, JAMA.

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages.

W. Lubitz, S. Paukner, T. Schlapp, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Bacterial Ghosts as Novel Efficient Targeting Vehicles for DNA Delivery to the Human Monocyte-Derived Dendritic Cells

D. Cholujová, J. Sedlák, U. Mayr, 2005, Journal of immunotherapy.

Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010

Ronald N. Jones, S. Paukner, H. Sader, 2013, Antimicrobial Agents and Chemotherapy.

Effective gene transfer to melanoma cells using bacterial ghosts.

D. Cholujová, J. Sedlák, U. Mayr, 2008, Cancer letters.

Anti-inflammatory Activity of Lefamulin in a Lipopolysaccharide-Induced Lung Neutrophilia Model

B. Hrvačić, S. Paukner, S. Gelone, 2020, bioRxiv.

In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China

S. Paukner, K. Waites, J. Jensen, 2016, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).

Ronald N. Jones, S. Paukner, H. Sader, 2012, The Journal of antimicrobial chemotherapy.

In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum β-Lactamase Inhibitor

S. Paukner, T. Šolmajer, U. Urleb, 2008, Antimicrobial Agents and Chemotherapy.

Sphingomonas pituitosa sp. nov., an exopolysaccharide-producing bacterium that secretes an unusual type of sphingan.

W. Lubitz, S. Paukner, E. Moore, 2001, International journal of systematic and evolutionary microbiology.

Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials

S. Paukner, G. Moran, K. Waites, 2021, Antibiotics.

In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens

S. Paukner, J. Jensen, Astrid Gruss, 2018, Antimicrobial Agents and Chemotherapy.

Disk Diffusion and MIC Quality Control Ranges for BC-3205 and BC-3781, Two Novel Pleuromutilin Antibiotics

Ronald N. Jones, S. Paukner, H. Sader, 2012, Journal of Clinical Microbiology.

Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells.

W. Lubitz, S. Paukner, G. Kohl, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus

A. Bashan, A. Yonath, H. Rozenberg, 2015, Proceedings of the National Academy of Sciences.

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

T. File, S. Paukner, G. Talbot, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

for DNA Vaccines Bacterial Ghosts Are an Efficient Delivery System

W. Lubitz, S. Paukner, Carlos A. Thomas Ebensen, 2011 .

System for DNA Vaccines Bacterial Ghosts Are an Efficient Delivery

W. Lubitz, T. Ebensen, S. Paukner, 2004 .

Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery

W. Lubitz, S. Paukner, P. Kúdela, 2006, Expert opinion on drug delivery.

Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark

S. Paukner, J. Jensen, B. Afshar, 2022, The Journal of antimicrobial chemotherapy.

Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis

S. Paukner, K. Sands, O. B. Spiller, 2021, Antibiotics.

In Vitro Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae

M. Unemo, S. Jacobsson, S. Paukner, 2017, Antimicrobial Agents and Chemotherapy.

Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities

T. File, S. Paukner, G. Moran, 2021, BMC Pulmonary Medicine.

Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015–2016 and Characterization of Resistance Mechanisms

S. Paukner, S. Gelone, H. Sader, 2019, Antimicrobial Agents and Chemotherapy.

Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections

Ronald N. Jones, Helio S. Sader, Douglas J. Biedenbach, 2012, Antimicrobial Agents and Chemotherapy.

Pooled Microbiological Findings and Efficacy Outcomes by Pathogen in Adults With Community-Acquired Bacterial Pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Trials of Lefamulin Versus Moxifloxacin

T. File, S. Paukner, K. Waites, 2021, Journal of Global Antimicrobial Resistance.

Sealed bacterial ghosts--novel targeting vehicles for advanced drug delivery of water-soluble substances.

W. Lubitz, S. Paukner, K. Jalava, 2003, Journal of drug targeting.

In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice

S. Paukner, S. Gelone, W. Wicha, 2024, International journal of molecular sciences.